A detailed history of Guardian Asset Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Guardian Asset Advisors, LLC holds 4,581 shares of ABBV stock, worth $820,915. This represents 0.61% of its overall portfolio holdings.

Number of Shares
4,581
Previous 4,641 1.29%
Holding current value
$820,915
Previous $796 Million 13.67%
% of portfolio
0.61%
Previous 0.58%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$163.84 - $199.33 $9,830 - $11,959
-60 Reduced 1.29%
4,581 $905 Million
Q2 2024

Jul 15, 2024

SELL
$154.79 - $180.76 $13,621 - $15,906
-88 Reduced 1.86%
4,641 $796 Million
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $13,904 - $15,842
87 Added 1.87%
4,729 $861 Million
Q4 2023

May 03, 2024

BUY
$137.6 - $154.97 $638,739 - $719,370
4,642 New
4,642 $720 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Guardian Asset Advisors, LLC Portfolio

Follow Guardian Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Asset Advisors, LLC with notifications on news.